Diagnosis | Biopsy 1 | Biopsy 1 + 2 | Biopsy 1 + 2 + 3 | Biopsy 1 + 2 + 3 + 4 | ||||
---|---|---|---|---|---|---|---|---|
n | % (95%CI) | n | % (95%CI) | n | % (95%CI) | n | % (95%CI) | |
All included women (n = 173) | ||||||||
No dysplasia | 121 | 69.9 (62.5–76.7) | 102 | 59.0 (51.2–66.4) | 91 | 52.6 (44.9–60.2) | 76 | 43.9 (36.4–51.7) |
CIN1 | 33 | 19.1 (13.5–25.7) | 44 | 25.4 (19.1–32.6) | 52 | 30.1 (23.3–37.5) | 59 | 34.1 (27.1–41.7) |
CIN2+ | 19 | 11.0 (6.7–16.6) | 27 | 15.6 (10.5–21.9) | 30 | 17.3 (12.0–23.8) | 38 | 22.0 (16.0–28.9) |
Women without any visible changes of the cervix (n = 137) | ||||||||
No dysplasia | 100 | 73.0 (64.7–80.2) | 85 | 62.0 (53.4–70.2) | 76 | 55.5 (46.7–64.0) | 65 | 47.4 (38.9–56.1) |
CIN1 | 27 | 19.7 (13.4–27.4) | 37 | 27.0 (19.8–35.3) | 45 | 32.8 (25.1–41.4) | 50 | 36.5 (28.4–45.1) |
CIN2+ | 10 | 7.3 (3.6–13.0) | 15 | 10.9 (6.3–17.4) | 16 | 11.7 (6.8–18.3) | 22 | 16.1 (10.3–23.3) |
Women who underwent LEEP (n = 21) | ||||||||
No dysplasia | 5 | 23.8 (8.2–47.2) | 3 | 14.3 (3.0–36.3) | 3 | 14.3 (3.0–36.3) | 0 | 0.0 (0–16.1) |
CIN1 | 6 | 28.6 (11.3–52.2) | 4 | 19.0 (5.4–41.9) | 3 | 14.3 (3.0–36.3) | 3 | 14.3 (3.0–36.3) |
CIN2+ | 10 | 47.6 (25.7–70.2) | 14 | 66.7 (43.0–85.4) | 15 | 71.4 (47.8–88.7) | 18 | 85.7 (63.7–97.0) |